A new tool for grade II glioma studies: plotting cumulative time with quality of life versus time to malignant transformation
J Neurooncol
.
2012 Jan;106(1):213-5.
doi: 10.1007/s11060-011-0659-5.
Epub 2011 Jul 9.
Authors
Emmanuel Mandonnet
,
Hugues Duffau
,
Luc Bauchet
PMID:
21744076
DOI:
10.1007/s11060-011-0659-5
No abstract available
Publication types
Letter
MeSH terms
Brain Neoplasms / pathology*
Cell Transformation, Neoplastic*
Disease-Free Survival
Endpoint Determination
Glioma / pathology*
Humans
Quality of Life*
Risk Assessment
Survival